Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature
- PMID: 26745766
- DOI: 10.1021/acs.jmedchem.5b01599
Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature
Abstract
The autotaxin-lysophophatidic acid (ATX-LPA) signaling pathway is implicated in a variety of human disease states including angiogenesis, autoimmune diseases, cancer, fibrotic diseases, inflammation, neurodegeneration, and neuropathic pain, among others. As a result, ATX-LPA has become of significant interest within both the industrial and the academic communities. This review aims to provide a concise overview of the development of novel ATX inhibitors, including the disclosure of the first ATX clinical trial data.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous